https://www.cancerconference.gr/wp-content/uploads/2020/10/pagoni1.jpg
Αιματολόγος, Διευθύντρια, Αιματολογική – Λεμφωμάτων Κλινική & Μονάδα ΜΜΟ, Γ.Ν.A. «Ευαγγελισμός»

Μαρία Παγώνη


  1. EDUCATION & TRAINING
  • Boards Certification in Hematology (1991), Athens, Greece
  1. POSITIONS AND EMPLOYMENT
  • Hematologist, Fellow in Bone Marrow Transplantation Unit, Hematology – Lymphomas Dept and BMT Unit, Evangelismos General Hospital (1991–1992).
  • Hematologist in the Thalassemia Unit of IKA (Foundation of Social Insurance), Athens, Greece (1992-1994).
  • Hematologist in the 7th Hospital of IKA (Foundation of Social Insurance), Athens, Greece (1995-1996).
  • Consultant Hematologist in Hematology – Lymphomas Dept and BMT Unit, Evangelismos General Hospital (1996- present)
  1. SCIENTIFIC & RESEARCH ACTIVITIES
  • Clinical studies (currently 5 ongoing) testing novel targeted drugs in patients with hematological malignancies (mainly patients with acute myeloid leukemia, AML).
  • Clinical studies (international multicenter) in the TKI use in chronic myeloid leukemia and the investigation of the possibility of stopping the treatment (EUROSKI and EnestPATH)
  • Main Investigator in seven AML co-operative studies conducted by AML Working Party of Hellenic Society of Haematology.
  • Clinical and molecular studies in patients with acute promyelocytic leukemia (APL) both in the national and the international level (as Greek representative and administrator of APL registry).
  • Administrator of AML, APL and Mastocytosis registries in Greece and Cyprus.
  1. FELLOWSHIPS
  • Fellow in Bone Marrow Transplantation Unit, Hematology – Lymphoma Clinic and BMT Unit, Evangelismos General Hospital (1991 – 1992)
  1. AWARDS & DISTINCTIONS
  • 4 awards (2002-2016) for the best poster in several congresses.
  • Member of the Editorial Board of the scientific journal “Hospital Chronicles” and Guest Editor in Haema Vol. 8, issue 2 2017, special issue in AML.
  • Member of “The European LeukemiaNet” a publicly funded research network of excellence, funded by the 6th Framework Program of the European Community which integrates the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health.
  • Reviewer in 1 International Peer-Reviewed Journal (Meditarranean Journal of Hematology and Infectious Disease).
  • Member in 2 scientific societies (Hellenic Society of Haematology, Scientific Committee of Evangelismos Hospital).
  • Elected in the board of Hellenic Society of Haematology four times (served as Vice-President and Treasurer).I am being continuously elected from 2003 in AML and MPN Working Party of Hellenic Society of Haematology and served twice as President, thrice as Vice-President and twice as Secretary.
  • Invited speaker in 120 International and National Congresses (1990-2017). ‘
  1. EDUCATIONAL ACTIVITIES
  1. PUBLICATIONS
  • 30 publications in international peer-reviewed journals with impact factor.
  • One monograph in international peer-reviewed journals.
  • 200 presentations in international and national Congresses (82 international & 118 national) and publications in their abstract books.